Rights and permissions
About this article
Cite this article
Hib vax not cost-effective for infants in Moscow. Pharmacoecon. Outcomes News 500, 6 (2006). https://doi.org/10.2165/00151234-200605000-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605000-00013